The store will not work correctly when cookies are disabled.
2-((5-(2-methyl-5-nitrophenyl)furan-2-yl)methylene)benzo[b]thiophen-3(2H)-one
ID: ALA4796282
PubChem CID: 1041870
Max Phase: Preclinical
Molecular Formula: C20H13NO4S
Molecular Weight: 363.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2\Sc3ccccc3C2=O)o1
Standard InChI: InChI=1S/C20H13NO4S/c1-12-6-7-13(21(23)24)10-16(12)17-9-8-14(25-17)11-19-20(22)15-4-2-3-5-18(15)26-19/h2-11H,1H3/b19-11-
Standard InChI Key: ABAMPLTYAXDEBF-ODLFYWEKSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-0.1059 -13.1245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1047 -13.9441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6064 -14.3531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6046 -12.7157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3133 -13.1209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3135 -13.9441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0965 -14.1983 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5802 -13.5321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0961 -12.8664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3484 -12.0891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3974 -13.5319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8062 -14.2394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4709 -14.9835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0784 -15.5301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7860 -15.1212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6157 -14.3220 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4903 -15.5281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4901 -16.3464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1976 -16.7539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9057 -16.3443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9019 -15.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1939 -15.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6087 -15.1095 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6047 -14.2924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3184 -15.5146 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7826 -16.7553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 2 0
8 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 17 1 0
23 24 2 0
23 25 1 0
21 23 1 0
18 26 1 0
M CHG 2 23 1 25 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 363.39 | Molecular Weight (Monoisotopic): 363.0565 | AlogP: 5.49 | #Rotatable Bonds: 3 |
Polar Surface Area: 73.35 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.76 | CX LogD: 4.76 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.35 | Np Likeness Score: -1.54 |
References
1. Hou X,Sun JP,Ge L,Liang X,Li K,Zhang Y,Fang H. (2020) Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets., 190 [PMID:32078861] [10.1016/j.ejmech.2020.112131] |